Analysis of the effect of clinical and laboratory parameters on survival in patients with metastatic renal cell cancer with intermediate prognosis according to IMDC (International mRCC Database Consortium)

D. V. Semenov; R. V. Orlova; V. I. Shirokorad; S. V. Kostritsky; M. I. Gluzman; S. G. Grigoriev; Yu. S. Korneva

Urology Herald
Vestnik Urologii

ISSN 2308-6424 (Online)

User

eng | рус

Urology Herald

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritsky S.V., Gluzman M.I., Grigoriev S.G., Korneva Yu.S. Analysis of the effect of clinical and laboratory parameters on survival in patients with metastatic renal cell cancer with intermediate prognosis according to IMDC (International mRCC Database Consortium). Urology Herald. 2023;11(2):110-121. (In Russ.) https://doi.org/10.21886/2308-6424-2023-11-2-110-121

Views PDF (Rus): 343

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2308-6424 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Vladimir P. Glukhov

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

D. V. Semenov
St. Petersburg City Clinical Oncological Dispensary; St. Petersburg State University
Russian Federation

Dmitry V. Semenov — M.D., Сand.Sc.(Med); Assoc.Prof., Dept. of Oncology, Faculty of Medicine, St. Petersburg State University; Oncological Urologist, Oncological Urology Division, St. Petersburg City Clinical Oncological Dispensary.

St. Petersburg

R. V. Orlova
St. Petersburg City Clinical Oncological Dispensary; St. Petersburg State University
Russian Federation

Rashida V. Orlova — M.D., Dr.Sc.(Med), Full Prof.; Head, Dept. of Oncology, Faculty of Medicine, St. Petersburg State University; Chief Specialist in Clinical Oncology, St. Petersburg City Clinical Oncological Dispensary.

St. Petersburg

V. I. Shirokorad
Moscow City Oncological Hospital No. 62
Russian Federation

Valeriy I. Shirokorad — M.D., Dr.Sc.(Med); Head, Oncological Urology Division, Moscow City Oncological Hospital No. 62.

Moscow

S. V. Kostritsky
Moscow City Oncological Hospital No. 62
Russian Federation

Stanislav V. Kostritsky — M.D.; Oncological Urologist, Oncological Urology Division, Moscow City Oncological Hospital No. 62.

Moscow

M. I. Gluzman
St. Petersburg City Clinical Oncological Dispensary; St. Petersburg State University
Russian Federation

Mark I. Gluzman — M.D., Сand.Sc.(Med); Assoc.Prof., Dept. of Oncology, Faculty of Medicine, St. Petersburg State University; Head, Dept. of Antitumor Drug Therapy, St. Petersburg City Clinical Oncological Dispensary.

St. Petersburg

S. G. Grigoriev
Kirov Military Medical Academy
Russian Federation

Stepan G. Grigoriev — M.D., Dr.Sc.(Med), Full Prof.; Senior Researcher, Research Institute of Medical Information Technologies, Kirov Military Medical Academy.

St. Petersburg

Yu. S. Korneva
St. Petersburg City Hospital No. 26; Smolensk State Medical University; Mechnikov North-Western State Medical University
Russian Federation

Yulia S. Korneva — M.D., Сand.Sc.(Med); Assoc.Prof., Dept. of Pathology, Smolensk State Medical University; Assoc.Prof., Dept. of Pathology, Mechnikov North-Western State Medical University; Pathologist, Pathology Division, St. Petersburg City Hospital No. 26

Smolensk, St. Petersburg

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Urology Herald

For citations:

Cookies policy